Asian Institute of Medical Sciences
PrivateLast Round
M&A
Jul 25, 2024
Est. Valuation
$180M
Total Funding Raised
$37.1M
Company Overview
Asian Institute of Medical Sciences operates in Healthcare & Life Sciences and is based in Faridabad. Its latest recorded funding round was a Series B round in November 2017.
Asian Institute of Medical Sciences is a multi-specialty hospital chain that provides comprehensive tertiary care medical services across North and East India.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Telemedicine, EHR & EMR, Patient Engagement
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asian Institute of Medical Sciences Comparables
Compare Asian Institute of Medical Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sarvodaya Healthcare | 92% | |
| Metro Group of Hospitals | 89% | |
| Paras Hospitals | 88% |
For institutional investors. Book with your work email.
Asian Institute of Medical Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jul 25, 2024 | ||||
| Buyout/LBO | Jun 19, 2024 | ||||
| Series B | Nov 27, 2017 | ||||
| Private Equity | Jan 9, 2014 |
For institutional investors. Book with your work email.
Asian Institute of Medical Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kohlberg Kravis Roberts | M&A |
| OrbiMed | Series B, Private Equity |
| 360 ONE Asset Management Limited | Buyout/LBO |
| Everstone Capital | M&A |
| General Atlantic | M&A |
| British International Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2025
Organized the "Asian Cyclothon" with 375 participants.
- Jan 1, 2025
Recognized as one of the Best Organizations to Work For in 2025.
For institutional investors. Book with your work email.
Asian Institute of Medical Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Asian Institute of Medical Sciences's valuation, stock price, and market status.
Is Asian Institute of Medical Sciences a public or private company?
Asian Institute of Medical Sciences is a private company.
What is the current stock price of Asian Institute of Medical Sciences?
Asian Institute of Medical Sciences is a private company, so its shares have no public market price. Caplight tracks Asian Institute of Medical Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Asian Institute of Medical Sciences worth (valuation)?
Asian Institute of Medical Sciences's valuation is estimated at $180.0M based on funding round data.
Can I buy Asian Institute of Medical Sciences stock?
Asian Institute of Medical Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Asian Institute of Medical Sciences's last funding round?
Asian Institute of Medical Sciences's most recent funding round was M&A on July 25, 2024.
Who are the main investors in Asian Institute of Medical Sciences?
Key investors in Asian Institute of Medical Sciences include OrbiMed, 360 ONE Asset Management Limited, British International Investment.
Will Asian Institute of Medical Sciences IPO soon?
No public IPO plans have been announced for Asian Institute of Medical Sciences.
How can I track Asian Institute of Medical Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Asian Institute of Medical Sciences's shares on secondary markets.